Home/Filings/4/A/0000891293-16-000080
4/A//SEC Filing

CTI BIOPHARMA CORP 4/A

Accession 0000891293-16-000080

CIK 0000891293operating

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 6:30 PM ET

Size

5.7 KB

Accession

0000891293-16-000080

Insider Transaction Report

Form 4/AAmended
Period: 2015-12-23
Bianco James A.
DirectorCEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2015-12-23+2,700,0002,700,000 total
    Exercise: $1.24Exp: 2025-12-23Common Stock (2,700,000 underlying)
Footnotes (2)
  • [F1]This report amends the report filed on December 23, 2015 in order to correct the number of shares subject to the option grant reported in Table II.
  • [F2]The option is scheduled to vest in eight semi-annual installments over the four-year period following the grant date, subject to the reporting person's continued employment or service with the issuer through the applicable vesting date.

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000891293

Filing Metadata

Form type
4/A
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:30 PM ET
Size
5.7 KB